Oaktree Acquisition Corp. III Life Sciences - 8-K Filing

Oaktree Acquisition Corp. III Life Sciences extends business combination deadline to November 25, 2026, and approves monthly extensions through May 2027. (Items: 3.02 Unregistered Sales of Equity Securities, 5.03 Amendments to Articles of Association or Bylaws; Change in Fiscal Year, 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits (d) Exhibits ExhibitNo)

SEC EDGAR ·

Tickers: $OACCU

Read the full article at SEC EDGAR

Part of the story La Rosa Holdings Corp. - 8-K Filing (6 articles)

More Regulatory news